Gå direkt till huvudinnehållet

Gulsot hos nyfödda

Publicerad:
Sakkunnig:
  1. Akobeng AK. Neonatal jaundice. Clin Evid 2004; 11: 460-7. PubMed  
  2. Moerschel SK, Cianciaruso LB, Tracy LR. A practical approach to neonatal jaundice. Am Fam Physician 2008; 77: 1255-62. PubMed  
  3. Rennie J, Burman-Roy S, Murphy MS. Neonatal jaundice: summary of NICE guidance. BMJ 2010; 340: c2409. BMJ (DOI)  
  4. Gale R, Seidman DS, Stevenson DK. Hyperbilirubinemia and early discharge. J Perinatol 2001; 21: 40-3. PubMed  
  5. Kernicterus in full-term infants - United States, 1994 - 1998. MMWR Morb Mortal Wkly Rep 2001; 50: 491-4. PubMed  
  6. Preer GL, Philipp BL. Understanding and managing breast milk jaundice. Arch Dis Child Fetal Neonatal Ed 2010; : PMID: 20688866 . PubMed  
  7. Hansen TWR. Kernicterus in term and near-term infants - the specter walks again. Acta Paediatr 2000; 89: 1155-7. PubMed  
  8. Turkel SB, Guttenberg ME, Moynes DR, et al. Lack of identifiable risk factors for kernicterus. Pediatrics 1980; 66: 502-6. Pediatrics  
  9. Hansen TWR. Jaundice, neonatal. eMedicine 2002; June 28: www.emedicine.com.
  10. Hankø E, Lindemann R, Hansen TWR. Spectrum of outcome in infants with extreme neonatal jaundice. Acta Paediatr 2001; 90: 782-5. PubMed  
  11. Gottstein R, Cooke RW. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2003; 88: F6-10. PubMed  
  12. Rennie J, Burman-Roy S, Murphy MS. Neonatal jaundice: summary of NICE guidance. BMJ 2010; 340: c2409. BMJ (DOI)  
  13. Djokomuljanto S, Quah BS, Surini Y, et al. Efficacy of phototherapy for neonatal jaundice is increased by the use of low-cost white reflecting curtains. Arch Dis Child Fetal Neonatal Ed 2006; 91: 439-42. PubMed  
  14. Rübo J, Albrecht K, Lasch P et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia cause by Rh hemolytic disease. J Pediatr 1992; 121: 93-7. PubMed  
  15. Riskin A, Tamir A, Kugelman A, Hemo M, Bader D. Is visual assessment of jaundice reliable as a screening tool to detect significant neonatal hyperbilirubinemia? J Pediatr 2008; 152: 782-7. PubMed  
  16. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316. Pediatrics  
  17. Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 2002; 140: 396-403. PubMed  
  18. Kaplan M, Hammerman C. Severe neonatal hyperbilirubinemia: a potential complication of glucose-6-phosphate dehydrogenase deficiency. Clin Perinatol 1998; 25: 575-90. PubMed  
  19. Mills JF, Tudehope D. Fibreoptic phototherapy for neonatal jaundice (Cochrane Review). In: The Cochrane Library. Issue 2, 2003. Oxford: Update Software. The Cochrane Library  
  20. Hansen TWR. Recent advances in pharmacotherapy for hyperbilirubinaemia in the neonate. Exp Opion Pharmacother 2003; 4: 1939-48. PubMed  
  21. Brown AK, Kim MH, Wu PYK, et al. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 1985; 75: 393-400. Pediatrics  
  22. Hansen TWR. Acute management of extreme neonatal jaundice - the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr 1997; 86: 843-6. PubMed  
  23. Hansen TWR. Therapeutic practices in neonatal jaundice: an international survey. Clin Pediatr 1996; 35: 309-16. PubMed  
  • Elisabeth Olhager, med dr och överläkare, Barn- och ungdomsmedicinska kliniken, Linköping-Motala

Tidigare sakkunniga

  • Ragnhild Støen, avdelningsöverläkare, dr. med., Nyfødt Intensiv seksjon, Barne- og Ungdomsklinikken, St. Olavs Hospital
  • Terje Johannessen, professor i allmänmedicin, Institutt for samfunnsmedisinske fag, Norges teknisk-naturvitenskapelige universitet, Trondheim